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Abstract
Over 11 million voluntary medical male circumcisions (VMMC) have been performed of the
projected 20.3 million needed to reach 80% adult male circumcision prevalence in priority
sub-Saharan African countries. Striking numbers of adolescent males, outside the 15-49-
year-old age target, have been accessing VMMC services. What are the implications of
overall progress in scale-up to date? Can mathematical modeling provide further insights
on how to efficiently reach the male circumcision coverage levels needed to create and sus-
tain further reductions in HIV incidence to make AIDS no longer a public health threat by
2030? Considering ease of implementation and cultural acceptability, decision makers may
also value the estimates that mathematical models can generate of immediacy of impact,
cost-effectiveness, and magnitude of impact resulting from different policy choices. This
supplement presents the results of mathematical modeling using the Decision Makers’
Program Planning Tool Version 2.0 (DMPPT 2.0), the Actuarial Society of South Africa
(ASSA2008) model, and the age structured mathematical (ASM) model. These models are
helping countries examine the potential effects on program impact and cost-effectiveness
of prioritizing specific subpopulations for VMMC services, for example, by client age, HIV-
positive status, risk group, and geographical location. The modeling also examines long-
term sustainability strategies, such as adolescent and/or early infant male circumcision, to
preserve VMMC coverage gains achieved during rapid scale-up. The 2016–2021 UNAIDS
strategy target for VMMC is an additional 27 million VMMC in high HIV-prevalence settings
by 2020, as part of access to integrated sexual and reproductive health services for men.
To achieve further scale-up, a combination of evidence, analysis, and impact estimates can
usefully guide strategic planning and funding of VMMC services and related demand-crea-
tion strategies in priority countries. Mid-course corrections now can improve cost-effective-
ness and scale to achieve the impact needed to help turn the HIV pandemic on its head
within 15 years.
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Introduction
Voluntary medicalmale circumcision (VMMC) program scale-up for HIV prevention has
been under way in settings with generalizedHIV epidemics and low prevalence of male cir-
cumcision, as recommended in 2007 by theWorld Health Organization (WHO) and the Joint
United Nations Programme on HIV/AIDS (UNAIDS) [1]. More than 11 millionmales in high
HIV-prevalence settings in sub-Saharan Africa have been circumcised [2] of the projected 20.3
million needed to reach 80% adult male-circumcision prevalence in priority countries by the
end of 2015 [3]. Undoubtedly, this is substantial progress, but will staying the course with cur-
rent strategies maximize HIV prevention benefits? Demand for VMMC services has been
lower than expected among men 30 years of age and older, while circumcision of young males
ages 10–14 years—an age group outside the original target of 15- to 49-year-olds—accounts
for nearly 35% of procedures performed to date [4]. Thus, it is timely for decisionmakers to
examine the implications of what has been achieved thus far and to consider prioritization
strategies informed by the results of mathematical modeling. Although broader impact would
be achieved if simply more men became circumcised, efficient resource utilization would man-
date strategic choices about who should be offered VMMC.
Current Context
In 2015, the UNAIDS/Lancet Commission spotlighted the urgent need to scale up AIDS
efforts, get serious about HIV prevention, and continue expanding access to treatment [5]. The
United States President’s Emergency Plan for AIDS Relief (PEPFAR) had already called for
doing the right things in the right places and at the right times to achieve an AIDS-free genera-
tion [6]. UNAIDS published a Fast Track Strategy to end AIDS as a public health threat by
2030 [7]. It set a short-term goal of reducing the number of newHIV infections globally to
fewer than 500,000 by 2020 and a longer-term goal of fewer than 200,000 by 2030 [7]. Strate-
gies included strengthening the HIV treatment cascade to achieve 90-90-90, meaning that 90%
of people living with HIV will know their HIV status, 90% of people who know their HIV sta-
tus will be on antiretroviral treatment (ART), and 90% of people on ART will be virally
supressed [7]. By 2030, the strategy aims to increase each of these treatment targets to 95%.
Achieving 90-90-90 would mean that by 2020, 73% of all people living with HIV would have
the viral suppression that brings individual clinical benefit and reduces HIV transmission risk
by 96% [8]. The Fast Track Strategy also called for renewed commitment to, sustained funding
for, and scaled-up implementation of HIV prevention programs, including VMMC programs
in the priority countries in eastern and southern Africa [9]. The UNAIDSWorld AIDS Day
Report [10] and the 2016–2021 UNAIDS strategy [11] have set a target of an additional 27 mil-
lion men in high HIV-prevalence settings being voluntarily medically circumcised by 2020, as
part of access to integrated sexual and reproductive health services for men.
Achieving these aims at country level requires a broad consensus on national goals to end
AIDS, target setting, sustained financing, and commitment to implementing effective programs
on the ground. In the face of plateauing international funding for HIV[12, 13], decisionmakers
at the country level have to mobilize increased domestic funding for HIV programs and decide
where best to allocate resources for the biggest impact on their HIV epidemics. They are cogni-
zant that every newHIV infectionmeans lifelong treatment need. AlthoughHIV incidence
may be on the decline in a given country, its decisionmakers may have data suggesting that
more people are acquiring HIV each day than are being placed on treatment [14]. These deci-
sion makers will be in a better position to make difficult choices about which strategies to pri-
oritize, which programs to scale up, and where best to invest efforts to achieve national goals if
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they are equipped with evidence, analysis, and impact estimates to inform effective decision
making for HIV prevention.
No one prevention modality on its own can rout a sexually transmitted HIV epidemic.
Combination prevention strategies involving biomedical, behavioral, and structural approaches
that work synergistically are essential [15]. VMMC, however, can make a unique contribution
to combination prevention: it is a single event without ongoing adherence challenges that has
lifetime direct benefits for men, along with indirect benefits for women and even for uncircum-
cisedmen [16].
Progress in VMMC Scale-Up and the Potential of Prioritization
Despite the striking achievement in scaling up VMMC, progress has been uneven across sub-
Saharan Africa and within countries. Mathematical modeling in 2011 estimated the number of
infections that would be averted for what cost and at what cost-savings to achieve 80%male
circumcision prevalence by the end of 2015 in high HIV prevalence countries [17]. It under-
scored the importance of VMMCwithin the HIV prevention portfolio and led PEPFAR to
include VMMC as one of the three key interventions needed to achieve an AIDS Free Genera-
tion. It informed the pace and overall scope of country strategies but did not examine the
potential effects of prioritization.
In reality, VMMC service scale-up has not necessarily focused on geographic areas with
high HIV prevalence within countries, but instead, in many cases, has expanded first in places
with greater ease of implementation, as programs focused on achieving an 80% population-
level male circumcision prevalence among 15- to 49-year-olds. As well, in many countries, the
males coming forward for male circumcision have not always been those at highest risk of
acquiring HIV, for whom reductions in HIV incidencemight be most immediate. Further-
more, adolescent males have been accessing VMMC services beyond expected numbers in
many countries, usually falling outside the lower bounds of age targets initially set by those
countries, and disproportionately to their age representation in the general population of
uncircumcisedmales (Fig 1). Although VMMC services should not be denied to any adolescent
or adult male who comes forward for male circumcision and who is medically eligible, the
funding of VMMC services and related demand creation strategies could prioritize high HIV-
incidence settings and certain age groups to achieve bigger impact. However, it is important to
realize that adolescent males who are not yet sexually active will naturally age into sexual activ-
ity that may put them at risk for HIV, whereas men ages 20–24 will also grow older, entering
the potentially higher-risk age categories of 25–29 years and 30–34 years.
What should guide strategic planning and implementation of VMMC programs? Though
not the sole information source, mathematical modeling can help to inform decisionmaking
by providing insights into potential future scenarios based on today’s programmatic decisions.
Decisionmakers may be most interested in immediacy of impact, or in cost-effectiveness, or in
the magnitude of impact of their decisions when they opt for one strategy over another. Alter-
natively, they may prioritize other factors not addressed by the modeling, such as cultural
acceptability and ease of implementation. Ending the HIV epidemic as quickly as possible
places priority on immediacy of impact, whereas a longer-term focus values magnitude and
sustainability of impact on HIV incidence. Both estimating the number of VMMC procedures
that are required to avert one HIV infection and determining the cost-effectiveness of VMMC
can allow comparison to other HIV prevention strategies.
If the question is what age group to prioritize for male circumcision, decisionmakers can
compare them. Based on the modeling undertaken for this journal supplement, priority age
groups can vary by country and by indicator of interest, as Table 1 shows. Althoughmany
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Fig 1. Comparison of VMMC client age groups to their representation in the general male population that is uncircumcised.
doi:10.1371/journal.pone.0160699.g001
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countries had initially aimed to achieve 80% male-circumcision prevalence in the age group
15–49 years [3], several countries that participated in the modeling exercises—including
Malawi [18], Swaziland [19], Uganda [20], and Zambia [21]—have revised their strategies and/
or operational plans to focus on achieving targets among younger age ranges (most frequently
10–34 years) to maximize a combination of impact, cost-effectiveness, and feasibility.
New Mathematical Models for Strategic Demand Creation
Prioritizing Subpopulations by Age and Geography
This supplement presents newmathematical models that can help countries examine the
potential effects of focusing on specific subpopulations for male circumcision services by age
and geography. The DecisionMakers’ Program Planning Tool, Version 2.0 (DMPPT 2.0),
developed by the USAID- and PEPFAR-funded Health Policy Project [27], is a compartmental
model that allows the user to analyze the effects of VMMC client age and of geography on pro-
gram impact and cost-effectiveness.This model was applied to five countries [28], all of which
subsequently made policy decisions based on the modeling results.
Based on the DMPPT 2.0 age analysis and the country’s programmatic experience,Malawi’s
VMMC strategy now focuses on males ages 10–34 years and prioritizes 14 of the 28 districts in
the country [18]. The DMPPT 2.0 model’s results in Tanzania reinforced the VMMC strategy
launched in 2010, giving the country new confidence in investing in circumcising adolescents
[22]. Modeling helped Swaziland set age-specific targets, balancing cost, impact, and feasibility,
that were harmonized with its national goal of 70% coverage by 2018 of men ages 10–49 years
[19]. Application of DMPPT 2.0 in Uganda led policymakers to propose males ages 10–34
years as a priority group for VMMC in Uganda’s application to the Global Fund [20]. In South
Africa, the DMPPT 2.0 modeling results did not support the geographic prioritization of spe-
cific provinces but did reveal that a strategy focusing on men ages 15–34 years would maximize
program benefits [23].
An age-structuredmathematical (ASM) model developed by researchers at Weil Cornell
Medical College, supported by the Bill & Melinda Gates Foundation, was applied to Zambia to
determine how subpopulation prioritization could increase program efficiency. It revealed that
epidemic impact and program efficiencywould be improved by prioritizing young males who
are sexually active or just before sexual debut, high HIV-prevalence geographic areas, and men
who are at highest risk of HIV acquisition [21]. Likewise, the ASMmodel applied to Zimbabwe
projected that program efficiencywould improve by prioritizing young sexually active males
and those whose sexual behaviour puts them at higher risk for acquiring HIV [24]. Including
males regardless of their HIV status in VMMC programs would increase program effectiveness
Table 1. Priority country-specific age groups by indicator of interest.
Indicator Malawi [18] Tanzania [22] Swaziland [19] South Africa [23] Uganda [20] Zambia [21] Zimbabwe [24]
Number of VMMC/HIV infections
averted
20–34 20–34 15–34 20–34 20–34 15–29 15–34
Immediacy of impact 20–34 20–34 20–29 20–34 20–34 15–24 15–24
Magnitude of impact 15–24 10–24 15–29 15–24 10–19 10–24 10–24
Cost-effectiveness 15–34 15–34 15–34 15–34 15–34 15–29 15–34
PEPFAR target [25, 26] 15–29 10–29 15–29 15–34 15–29 15–29 15–29
New country age target 10–34 10–34 10–34* TBD 10–34 TBD 13–29
* Swaziland new country age target: 50% coverage for neonates, 80% coverage among males ages 10–29 years, and 50% coverage among males ages
30–34 years.
doi:10.1371/journal.pone.0160699.t001
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if it increases VMMC uptake among men at higher risk of HIV acquisition and if VMMC in
HIV-positive men reduces their risk of the ulcerative sexually transmitted infections that
increase HIV shedding and transmission to women. Importantly, VMMC services can serve as
a valuable portal of entry linkingmen who are tested and found HIV-positive to the antiretro-
viral treatment that can result in viral suppression and reduced infectivity.
TheWorld Bank supported the adaption of a demographic and epidemiologicalmodel of
the HIV epidemic in South Africa—theASSA2008 model—to analyze the impact of VMMC
and track resulting financial savings from reducedHIV incidence using a costingmodule [29].
The return on investment was highest if males are circumcised between the ages of 20 and 25
years, but this return on investment declinedwith age steeply thereafter. In addition, a costing
exercise conducted by the Health Policy Project and the USAID- and PEPFAR-funded Project
SOAR (Supporting Operational AIDS Research) that systematically collected cost data from 33
national government- and PEPFAR-supported urban, rural, and peri-urbanVMMC facilities
in eight of South Africa’s nine provinces [30] revealed that unit costs were significantly higher
in public hospitals than in health centers and clinics. Direct costs could be reduced by 17% if
South Africa encouraged task shifting from doctors to nurses.
The VMMCmodeling collection also includes four papers that explore the impact of scale-
up progress thus far [4], the potential cost-effectiveness of increasing demand among 20- to
29-year-olds in Zimbabwe [31] the projected contribution of VMMC scale-up to the Fast
Track goals in light of the 90-90-90 and 95-95-95 treatment cascade targets [32], and the cost
and impact of introducing early infant male circumcision (EIMC) for long-term sustainability
of VMMC programs [33].
The age-specific impact, cost-effectiveness, and coverage attributable to male circumcisions
conducted through the end of 2014 were modeled to assess actual progress in comparison with the
scenario of achieving 80% coverage among men ages 15–49 years by 2015 in the original 12 prior-
ity countries and in Nyanza Province, Kenya [4]. This work usedDMPPT 2.1, which is an updated
version of DMPPT 2.0 that beginswith the onset of each country’s VMMCprogram and can vary
start and end dates for model outputs. The median estimated cost per HIV infection averted based
on actual VMMCs performed through 2014 was US$4,400. Strikingly, more than half of the pro-
jectedHIV infections averted were attributable to circumcising 10- to 19-year-old males.
The Goals module of the Spectrum suite of models [34] was used to assess the impact and
cost of VMMC scale-up in the context of the 90-90-90 targets for 2020 and the 95-95-95 targets
for 2030 [32]. Several scenarios were examined using data and treatment cascade aspirations
for Lesotho, Malawi, South Africa, and Uganda. Across all four countries, scaling up VMMC
would provide HIV incidence reductions additional to those achieved by reaching the viral
suppression targets of 90-90-90. Once VMMC coverage targets are met, annual program costs
(ART and VMMC combined) are lower than in the scenarios in which VMMC coverage
remains at 2015 levels. In addition, in the two scenarios in which the 90-90-90 targets were not
met, scaling up VMMC reducedHIV incidence to nearly the same levels as scaling up ART to
90-90-90 without further scale-up of VMMC.
The manuscript on progress toward VMMC targets revealed that some countries are reach-
ing 80% coverage among some age groups faster than was initially apparent by focusing on
numerical targets alone, raising the possibility that these countries could start planning for sus-
tainability earlier than they expected.What is the best implementation model for long-term
sustainability of VMMC programs, so that the gains in coverage achieved during the rapid
scale-up are not lost? One alternative that countries can consider is that of routinely offering
VMMC to all males in the 10- to 14-year-olds age group, to create a cohort-based replenish-
ment effect. Another alternative is to introduce EIMC strategies. EIMC is a simpler procedure
that requires no sutures and that, with parental consent, can be safely performed by trained,
VMMC for HIV Prevention: New Mathematical Models Data
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experienced, lower-cadre healthcare providers [35]. Although the introduction of EIMC now
would increase the overall numbers of circumcisions that are needed over the next decade,
models project that this would not increase the long-term costs, assuming that EIMC unit costs
are substantially lower than those of adolescent VMMC [33]. A third strategy would be to pro-
vide a routine offer of VMMC both for infant males and for 10- to 14-year-olds during the sus-
tainability phase of implementation.
Conclusion
Progress to date on VMMC scale-up for HIV prevention in sub-Saharan Africa has been truly
impressive. Millions of men and adolescents have come forward to receive VMMC in settings
with high HIV prevalence and low male-circumcision prevalence. At issue now is how to effi-
ciently reach the levels of male circumcision coverage needed to create and sustain further
reductions in HIV incidence toward the 2030 goal of a world in which AIDS is no longer a pub-
lic health threat.
Modeling work using DMPPT 1.0 (the predecessor of DMPPT 2.0) informed the initial tar-
gets of the UNAIDS Joint Strategic Action Framework to Accelerate the Scale-Up of Voluntary
Medical Male Circumcision for HIV Prevention in Eastern and Southern Africa 2012–2016
[36]. Likewise, the results of the modeling work using DMPPT 2.0 published in this supple-
ment are expected to play an important role in the development of WHO’s new action frame-
work on VMMC in the context of Fast Track and combination prevention. Moreover, this
work can guide country programs as they establish and work toward their new age-specific
coverage targets and prepare for sustainability.
The focus is shifting from the original 80% male-circumcision prevalence target for males
ages 15–49 years. Countries are being re-energized in their efforts to achieve more feasible,
realistic targets that will have nearly the same epidemiologic impact as earlier, more ambitious
targets promised. Geographic and age prioritization, combined with tailored, effective demand
creation and expanding VMMC choices through the introduction of new devices alongside
current conventional surgical techniques [37], will speed the HIV incidence reductions that
VMMC can accomplish. It is time now for the mid-course corrections that will improve cost-
effectiveness and achieve impact to help turn the HIV pandemic on its head within 15 years.
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